Share this article
Share this article
ST. LOUIS, April 1, 2021 /PRNewswire/ Hicuity Health, the nation s leading provider of high-acuity telemedicine services, has announced the extension of its longstanding relationship with Appalachian Regional Healthcare with the launch of its comprehensive tele-ICU care services at Highlands ARH Regional Medical Center (Prestonsburg, KY). The facility is the 13
th facility in the Appalachian Regional Healthcare system to implement Hicuity Health s technology-enabled care services to support the hospital s bedside team with 24 x 7 x 365 intensivist-led critical care and ensure system-wide consistency of care. Appalachian Regional Healthcare is excited to extend its Hicuity Health tele-ICU partnership to Highlands ARH Regional Medical Center. One of our system s goals in undertaking tele-ICU care two years ago was to ensure consistent delivery of critical care across the system. With this implementation, our newest hospital will now en
Novari Surgical Wait List Technology to be Deployed at Muskoka Algonquin Healthcare
News provided by
Share this article
Share this article
KINGSTON, ON, April 1, 2021 /CNW/ - Novari Health has announced that it has executed an agreement with Muskoka Algonquin Healthcare to immediately implement its surgical wait list management and eBooking technology.
The Novari ATC software is being implemented at Muskoka Algonquin Healthcare. The technology is being provided as software as a service (SaaS) to the hospital and all surgical offices. The system will provide these surgeons and their office staff access to a standardized electronic wait list management system and the ability to electronically coordinate the scheduling of surgeries and procedures with the hospital. The software enhances the ability for collaboration and management of pooled lists of patients waiting for surgery as well as supporting a regional view of the demand for surgical services.
Aeglea BioTherapeutics to Participate in Two Virtual Investor Conferences in April 2021
News provided by
Share this article
Share this article
AUSTIN, Texas, April 1, 2021 /PRNewswire/ Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics to benefit people with rare metabolic diseases, today announced it will participate in two virtual investor conferences in April 2021.
Conference Details
Conference Date: Tuesday, April 6 and Thursday, April 8
Participants: Anthony G. Quinn, M.B. Ch.B., Ph.D., Aeglea s president and chief executive officer and Michael C. Hanley, Aeglea s chief commercial officer
Conference Name: 20
Conference Date: Monday, April 12 through Thursday, April 15
Share this article
Share this article
ALBANY, N.Y., April 1, 2021 /PRNewswire/ The widespread utilization of cerebral somatic oximeters in both non-hemostasis and hemostasis applications is likely to propel the growth of the global cerebral somatic oximeters market in the years to come. In addition to that, the increasing utilisation of cerebral somatic oximeters by various end users such as ambulatory surgical centres, hospitals, and clinics is estimated to bode well for the said market in the years to come. Less oxygen supply to the brain induces neurological disorders and brain damage conditions including hypoxic-ischemic encephalopathy (HIE). As a result, demand for cerebral oximeters is expected to rise as the incidence of cerebral hypoxia increases.
ISHLT s First All Virtual Annual Meeting to Kick off This Month
ISHLT2021 provides live and on-demand education for the advanced heart and lung failure community
News provided by
Share this article
Share this article
ADDISON, Texas, April 1, 2021 /PRNewswire/ The International Society of Heart and Lung Transplantation (ISHLT) will host its
41
st Annual Meeting & Scientific Sessions on 24-28 April, 2021. The all-virtual event will include educational content spanning the breadth of clinical practice and research concerning heart and lung transplantation, advanced heart and lung disease, mechanical circulatory support, and pulmonary vascular disease. The historic and inaugural virtual 41
st Annual Scientific Meeting of the ISHLT is just weeks away, says